Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 857270, 9 pages
http://dx.doi.org/10.1155/2014/857270
Research Article

Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index

1Laboratory of Molecular and Cellular Endocrinology, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS) and Santiago de Compostela University (USC), 15706 Santiago de Compostela, Spain
2CIBER Fisiopatología de la Obesidad y la Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain
3Obesidómica Group, Laboratory 3, Health Research Institute of Santiago (IDIS), University Hospital of Santiago (XXIS/SERGAS), 15706 Santiago de Compostela, Spain
4Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain
5Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, 08907 Barcelona, Spain
6Department of Clinical Sciences, School of Medicine, University of Barcelona, 08007 Barcelona, Spain
7Department of Psychological, Personality, Evaluation and Treatment of the University of Valencia, 46010 Valencia, Spain
8Department of Basic Psychology, Clinic and Psychobiology of the Jaume I University, Castelló, 12071 Castelló de la Plana, Spain
9Human Pharmacology and Clinical Neurosciences Research Group, Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
10Center for Genomic Regulation (CRG), 08003 Barcelona, Spain
11Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP), 08036 Barcelona, Spain
12Department of Diabetes, Endocrinology and Nutrition, Institut d’Investigació Biomèdica de Girona (IdlBGi), Hospital Dr Josep Trueta, Girona, Spain
13Department of Diabetes, Endocrinology and Nutrition, Hospital Cliínico Universitario Virgen de Victoria, 29010 Maálaga, Spain
14Department of Endocrinology and Nutrition, University Clinic de Navarra, University of Navarra, 31008 Pamplona, Spain

Received 12 December 2013; Revised 28 February 2014; Accepted 28 February 2014; Published 22 April 2014

Academic Editor: Maria L. Dufau

Copyright © 2014 María Pardo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Villarejo, F. Fernández-Aranda, S. Jiménez-Murcia et al., “Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates,” European Eating Disorders Review, vol. 20, no. 3, pp. 250–254, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Treasure, V. Cardi, and C. Kan, “Eating in eating disorders,” European Eating Disorders Review, vol. 20, no. 1, pp. e42–e49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. López, S. Tovar, M. J. Vázquez, L. M. Williams, and C. Diéguez, “Peripheral tissue-brain interactions in the regulation of food intake,” Proceedings of the Nutrition Society, vol. 66, no. 1, pp. 131–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. B. K. Pedersen and M. A. Febbraio, “Muscles, exercise and obesity: skeletal muscle as a secretory organ,” Nature Reviews Endocrinology, vol. 8, pp. 457–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Pardo, A. Roca-Rivada, L. M. Seoane, and F. F. Casanueva, “Obesidomics: contribution of adipose tissue secretome analysis to obesity research,” Endocrine, vol. 41, pp. 374–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. B. K. Pedersen, “The diseasome of physical inactivity—and the role of myokines in muscle-fat cross talk,” The Journal of Physiology, vol. 587, no. 23, pp. 5559–5568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Boström, J. Wu, M. P. Jedrychowski et al., “A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis,” Nature, vol. 481, no. 7382, pp. 463–468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Handschin and B. M. Spiegelman, “The role of exercise and PGC1α in inflammation and chronic disease,” Nature, vol. 454, no. 7203, pp. 463–469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Cunha, “Basic research: irisin—behind the benefits of exercise,” Nature Reviews Endocrinology, vol. 8, no. 4, p. 195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Sanchis-Gomar, G. Lippi, S. Mayero, C. Perez-Quilis, and J. L. Garcia-Gimenez, “Irisin: a new potential hormonal target for treatment of obesity and type II diabetes,” Journal of Diabetes, vol. 4, p. 196, 2012. View at Publisher · View at Google Scholar
  11. F. Villarroya, “Irisin, turning up the heat,” Cell Metabolism, vol. 15, no. 3, pp. 277–278, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. D. P. Kelly, “Medicine: irisin, light my fire,” Science, vol. 335, no. 6077, pp. 42–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Castillo-Quan, “From white to brown fat through the PGC-1alpha-dependent myokine irisin: implications for diabetes and obesity,” Disease Models & Mechanisms, vol. 5, pp. 293–295, 2012. View at Publisher · View at Google Scholar
  14. A. Stengel, T. Hofmann, M. Goebel-Stengel, U. Elbelt, P. Kobelt, and B. F. Klapp, “Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index,” Peptides, vol. 39, pp. 125–130, 2012. View at Google Scholar
  15. J. Y. Huh, G. Panagiotou, V. Mougios et al., “FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise,” Metabolism: Clinical and Experimental, vol. 61, pp. 1725–1738, 2012. View at Publisher · View at Google Scholar
  16. A. Roca-Rivada, C. Castelao, L. L. Senin et al., “FNDC5/irisin is not only a myokine but also an adipokine,” PLoS ONE, vol. 8, Article ID e60563, 2013. View at Google Scholar
  17. A. B. Crujeiras, M. Pardo, A. Roca-Rivada et al., “Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women,” American Journal of Human Biology, vol. 26, no. 2, pp. 198–207, 2014. View at Publisher · View at Google Scholar
  18. J. M. Moreno-Navarrete, F. Ortega, M. Serrano et al., “Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance,” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 4, pp. E769–E778, 2013. View at Publisher · View at Google Scholar
  19. K. Hojlund and P. Bostrom, “Irisin in obesity and type 2 diabetes,” Journal of Diabetes and Its Complications, vol. 27, pp. 303–304, 2013. View at Publisher · View at Google Scholar
  20. Association AP, APA, DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, 2000.
  21. M. B. First, S. Donovan, and A. Frances, “Nosology of chronic mood disorders,” Psychiatric Clinics of North America, vol. 19, no. 1, pp. 29–39, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. M. B. First, R. Spitzer, M. Gibbon, and J. Williams, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/P), Biometrics Research, New York State Psychiatric Institute, New York, NY, USA, 2002.
  23. D. P. Goldberg, Manual of the General Health Questionnaire (GHQ-28), NFER Nelson, Toronto, Canada, 1981.
  24. G. W. Strain, J. Wang, M. Gagner, A. Pomp, W. B. Inabnet, and S. B. Heymsfield, “Bioimpedance for severe obesity: comparing research methods for total body water and resting energy expenditure,” Obesity, vol. 16, no. 8, pp. 1953–1956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. C. Routen, D. Upton, M. G. Edwards, and D. M. Peters, “Intra-and inter-instrument reliability of the actiwatch 4 accelerometer in a mechanical laboratory setting,” Journal of Human Kinetics, vol. 31, no. 1, pp. 17–24, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. C. van der Pas, J. A. Verbunt, D. E. Breukelaar, R. van Woerden, and H. A. Seelen, “Assessment of arm activity using triaxial accelerometry in patients with a stroke,” Archives of Physical Medicine and Rehabilitation, vol. 92, no. 9, pp. 1437–1442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  28. R. Mera, H. Thompson, and C. Prasad, “How to calculate sample size for an experiment: a case-based description,” Nutritional Neuroscience, vol. 1, pp. 87–91, 1998. View at Google Scholar
  29. A. B. Crujeiras, M. A. Zulet, P. Lopez-Legarrea et al., “Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients,” Metabolism: Clinical and Experimental, vol. 63, no. 4, pp. 520–531, 2014. View at Publisher · View at Google Scholar
  30. R. de la Iglesia, P. Lopez-Legarrea, A. B. Crujeiras et al., “Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients,” Clinical Endocrinology, 2014. View at Publisher · View at Google Scholar
  31. P. Lopez-Legarrea, R. de la Iglesia, A. B. Crujeiras et al., “Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects,” Nutrition and Diabetes, vol. 4, article e110, 2014. View at Publisher · View at Google Scholar
  32. A. Swick, S. Orena, and A. O'Connor, “Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass,” Metabolism: Clinical and Experimental, vol. 62, pp. 1070–1073, 2013. View at Publisher · View at Google Scholar
  33. A. Hecksteden, M. Wegmann, A. Steffen et al., “Irisin and exercise training in humans—results from a randomized controlled training trial,” BMC Medicine, vol. 11, article 235, 2013. View at Google Scholar
  34. J. A. Timmons, K. Baar, P. K. Davidsen, and P. J. Atherton, “Is irisin a human exercise gene?” Nature, vol. 488, pp. E9–E10, 2012. View at Publisher · View at Google Scholar
  35. R. R. Kraemer, P. Shockett, N. D. Webb, U. Shah, and V. D. Castracane, “A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women,” Hormone and Metabolic Research, vol. 46, no. 2, pp. 150–154, 2014. View at Publisher · View at Google Scholar
  36. M. D. Roberts, D. S. Bayless, J. M. Company et al., “Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats,” Metabolism: Clinical and Experimental, vol. 62, no. 8, pp. 1052–1056, 2013. View at Publisher · View at Google Scholar
  37. A. Swick, S. Orena, and A. O'Connor, “Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass,” Metabolism: Clinical and Experimental, vol. 62, pp. 1070–1073, 2013. View at Publisher · View at Google Scholar
  38. M. G. Myers, R. L. Leibel, R. J. Seeley, and M. W. Schwartz, “Obesity and leptin resistance: distinguishing cause from effect,” Trends in Endocrinology and Metabolism, vol. 21, no. 11, pp. 643–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. K. A. Virtanen, M. E. Lidell, J. Orava et al., “Functional brown adipose tissue in healthy adults,” The New England Journal of Medicine, vol. 360, no. 15, pp. 1518–1525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. C. Zingaretti, F. Crosta, A. Vitali et al., “The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue,” FASEB Journal, vol. 23, no. 9, pp. 3113–3120, 2009. View at Publisher · View at Google Scholar · View at Scopus